News
Recently, Regeneron ( REGN -1.41%) entered an agreement to acquire 23andMe for $256 million, which is a tiny fraction of its ...
13hon MSN
GSK plc (NYSE:GSK) has strengthened its market outlook following major regulatory milestones. The U.S. FDA’s recent approval ...
Recent health news showcases key developments across various sectors. Jiangsu Hengrui and Mirxes have strong trading debuts, ...
1hOpinion
San Gabriel Valley Tribune on MSNColumn: From ‘Buffy’ to two famous moms advocating for protecting everyone’s childrenAlyson Hannigan and Sarah Michelle Gellar were teen actresses together. Now both moms to teens themselves, they’re raising ...
The U.S Food and Drug Administration has approved Nucala, British drugmaker GSK's asthma drug, to treat some patients with a ...
Despite world-class infrastructure and billion-dollar investments, Singapore’s biomedical sector remains under the radar. As ...
GSK’s Nucala receives US FDA approval for use in adults with chronic obstructive pulmonary disease: London, UK Saturday, May 24, 2025, 11:00 Hrs [IST] GSK plc announced that the ...
The final week of May is very promising on the stock market for its dividend paying stocks. A plenty of companies have ...
Publicly listed companies with foreign majority ownership on the NGX repatriated approximately $2.8 billion to their parent ...
Google India has renewed its lease for approximately 8.7 lakh square feet of office space in Bengaluru for another five years, with an annual rental value of Rs 90 crore, according to lease documents ...
Trump's tariff threats on EU and Apple sent European markets tumbling while FTSE 100 closed modestly lower, sterling surprisingly strengthened.
Gilead Sciences, Inc. (NASDAQ:GILD) has revealed encouraging results from its ASCENT-03 clinical trial, showcasing a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results